| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.096 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |